文献速递肿瘤 PET/CT神经核医学

整合分析[18F]FDG PET参数与浸润免疫细胞评分对肺腺癌的预后影响

Prognostic impact of an integrative analysis of [18F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma.
PubMed 文献 · EJNMMI Res · 2022-06-27

本研究整合[18F]FDG PET参数与基因组分析获得的浸润免疫细胞评分,对肺腺癌患者进行预后分层。高TLR评分与更差预后相关,而高CD8 T细胞和TFH评分预示更好预后;TLR和TFH可独立预测肺腺癌患者预后。

要点

  • 高TLR评分与肺腺癌更差预后相关,高CD8 T细胞和TFH评分预示更好预后。
  • TLR和TFH可独立预测肺腺癌患者预后。
  • 近端炎症型组CYT评分显著高于其他组(P = .001)。

核心结论

  • 高TLR评分与更差预后相关,而高CD8 T细胞和TFH评分预示更好预后。
  • TLR和TFH可独立预测肺腺癌患者预后。

研究设计与样本

  • 利用RNA测序数据集将患者分为三个亚型组,并获得24种不同免疫细胞评分和溶细胞评分(CYT)。
  • 获取原发肿瘤的18F-FDG PET参数,进行ANOVA检验、卡方检验和相关性分析。
  • 采用Kaplan-Meier生存分析联合对数秩检验和多变量Cox回归评估参数的预后价值。

主要发现

  • 终末呼吸单位(TRU)组较其他组显示更低的18F-FDG PET参数、更多女性及更低分期。
  • 近端炎症(PI)组CYT评分显著高于其他组(P = .001)。
  • 在PI组中,CYT与肿瘤与肝脏最大标准化摄取值比值(TLR)呈正相关(P = .027)。
  • 18F-FDG PET参数中高TLR评分(P = .01)与免疫细胞评分中高TFH评分(P = .005)与预后相关且趋势相反。
  • 调整临床病理特征等后,TLR和TFH仍可预测总生存(P = .024和.047)。

关键数值与推荐

  • PI组CYT评分显著高于其他组(P = .001)。
  • PI组中CYT与TLR呈正相关(P = .027)。
  • 高TLR评分与预后相关(P = .01),高TFH评分与预后相关(P = .005),两者趋势相反。
  • 调整临床病理特征等后,TLR预测总生存P = .024,TFH预测总生存P = .047。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High levels of 18F-fluorodeoxyglucose (18F-FDG) tumor uptake are associated with worse prognosis in patients with non-small cell lung cancer (NSCLC). Meanwhile, high levels of immune cell infiltration in primary tumor have been linked to better prognosis in NSCLC. We conducted this study for precisely stratified prognosis of the lung adenocarcinoma patients using the integration of 18F-FDG positron emission tomography (PET) parameters and infiltrating immune cell scores as assessed by a genomic analysis. RESULTS: Using an RNA sequencing dataset, the patients were divided into three subtype groups. Additionally, 24 different immune cell scores and cytolytic scores (CYT) were obtained. In 18F-FDG PET scans, PET parameters of the primary tumors were obtained. An ANOVA test, a Chi-square test and a correlation analysis were also conducted. A Kaplan-Meier survival analysis with the log-rank test and multivariable Cox regression test was performed to evaluate prognostic values of the parameters. The terminal respiratory unit (TRU) group demonstrated lower 18F-FDG PET parameters, more females, and lower stages than the other groups. Meanwhile, the proximal inflammatory (PI) group showed a significantly higher CYT score compared to the other groups (P = .001). Also, CYT showed a positive correlation with tumor-to-liver maximum standardized uptake value ratio (TLR) in the PI group (P = .027). A high TLR (P = .01) score of 18F-FDG PET parameters and a high T follicular helper cell (TFH) score (P = .005) of immune cell scores were associated with prognosis with opposite tendencies. Furthermore, TLR and TFH were predictive of overall survival even after adjusting for clinicopathologic features and others (P = .024 and .047). CONCLUSIONS: A high TLR score was found to be associated with worse prognosis, while high CD8 T cell and TFH scores predicted better prognosis in lung adenocarcinoma. Furthermore, TLR and TFH can be used to predict prognosis independently in patients with lung adenocarcinoma.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Choi J, Sarker A, Choi H, et al. Prognostic impact of an integrative analysis of [18F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma. EJNMMI Res. 2022. PMID: 35759068. doi:10.1186/s13550-022-00908-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。